Indikationen und Ergebnisse der Radiojodtherapie beim differenzierten Schilddrüsenkarzinom

BACKGROUND: Malignant tumors of the thyroid gland are the most frequent malignant endocrine neoplasms, comprising approximately 1% of all malignant tumors. In recent years there has been a clear rise in the incidence of differentiated thyroid carcinomas (DTC), especially small papillary carcinomas....

Descripción completa

Detalles Bibliográficos
Autor principal: Riemann, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Leitthema
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716916/
https://www.ncbi.nlm.nih.gov/pubmed/32749499
http://dx.doi.org/10.1007/s00104-020-01248-x
Descripción
Sumario:BACKGROUND: Malignant tumors of the thyroid gland are the most frequent malignant endocrine neoplasms, comprising approximately 1% of all malignant tumors. In recent years there has been a clear rise in the incidence of differentiated thyroid carcinomas (DTC), especially small papillary carcinomas. OBJECTIVE: Indications for and results of radioiodine treatment (RAI) of DTC. MATERIAL AND METHODS: A review of the current literature and guidelines of RAI in DTC was carried out. RESULTS: The use of RAI is the most important adjuvant treatment option for DTC and is generally well-tolerated. CONCLUSION: Due to the combination of surgery and RAI the DTC has a very good prognosis compared with other cancers, with an average survival rate of more than 90%.

Ejemplares similares